While markets are higher Tuesday, there is little to suggest recent choppy action won't continue.
A week of bad news for Ride Aid may be good news for its competitors Walgreens and CVS.
XRAY's long-term record suggests its sharp pullback was/is still a good buying chance.
An updated strategy for the high-flying REGN.
It is time for investors to start differentiating between the Good, the Bad and the Ugly in cannabis stocks.
Remembering these 'rules of the road' is vital in this highly volatile space.
BAX declined recently to break the rising 50-day moving average line.
Short-term price action may be volatile, but this name is still bullish long term.
The diversified company's charts are giving investors and traders the green light to go long.
Our latest analysis and strategy on ABT shares.

Columnist Conversations noted significant insider purchases in the beat-up shares of Newell (NWL). The stock is...
CEO Christian Brickman couldn't resist owning more Sally Beauty Holdings (SBH) when it briefly went below $14 ...
Move over Boca Biff - there is a new sheriff in town...Chance Walker! My conversation with Chance - high abov...
Oil tested its 200-day moving average this week, but the June 18 low of $63.59 a barrel held. As a result, we...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.